{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T02:39:08Z","timestamp":1774147148519,"version":"3.50.1"},"reference-count":13,"publisher":"Japanese Society of Internal Medicine","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2169\/internalmedicine.8865-17","type":"journal-article","created":{"date-parts":[[2017,9,5]],"date-time":"2017-09-05T22:12:08Z","timestamp":1504649528000},"page":"2579-2582","source":"Crossref","is-referenced-by-count":12,"title":["Naratriptan in the Prophylactic Treatment of Cluster Headache"],"prefix":"10.2169","volume":"56","author":[{"given":"Yasuo","family":"Ito","sequence":"first","affiliation":[{"name":"Department of Neurology, Saitama Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Mitsufuji","sequence":"additional","affiliation":[{"name":"Department of Neurology, Saitama Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Asano","sequence":"additional","affiliation":[{"name":"Saitama Neuropsychiatric Institute, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomokazu","family":"Shimazu","sequence":"additional","affiliation":[{"name":"Saitama Neuropsychiatric Institute, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Kato","sequence":"additional","affiliation":[{"name":"Saitama Medical University International Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Tanahashi","sequence":"additional","affiliation":[{"name":"Saitama Medical University International Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Maruki","sequence":"additional","affiliation":[{"name":"Saitama Neuropsychiatric Institute, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiko","family":"Sakai","sequence":"additional","affiliation":[{"name":"Saitama Neuropsychiatric Institute, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshimasa","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Neurology, Saitama Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuo","family":"Araki","sequence":"additional","affiliation":[{"name":"Department of Neurology, Saitama Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. G\u00f6bel H, Linder V, Heinze A, Ribbat M, Deuschi G. Acute therapy for cluster headache with sumatriptan: findings of a one-year long-term study. Neurology 51: 908-911, 1998.","DOI":"10.1212\/WNL.51.3.908"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ekbom K, Krabbe A, Micieli G, et al. Cluster headache attacks treated for up to three months with subcutaneous sumatriptan (6 mg). Sumatriptan Cluster Headache Long-term Study Group. Cephalalgia 15: 230-236, 1995.","DOI":"10.1046\/j.1468-2982.1995.015003230.x"},{"key":"3","unstructured":"3. Clinical Practice Guideline for Chronic Headache 2013. Available from: http:\/\/www.neurology-jp.org\/guidelinem\/ch\/index.html"},{"key":"4","unstructured":"4. Leone M, DAmico D, Frediani F, et al. Verapamil in the prophylaxis of episodic cluster headache: double-blind study versus placebo. Neurology 54: 1382-1385, 2000."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Saper JR, Klapper J, Mathew NT, Rapoport A, Phillips SB, Bernstein JE. Intranasal civamide for the treatment of episodic cluster headaches. Arch Neurol 59: 990-994, 2002.","DOI":"10.1001\/archneur.59.6.990"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. May A, Leone M, Afra J, et al. EFNS Task Force. EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias. Eur J Neurol 13: 1066-1077, 2006.","DOI":"10.1111\/j.1468-1331.2006.01566.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Eekers PJ, Koehler PJ. Naratriptan prophylactic treatment in cluster headache. Cephalalgia 21: 75-76, 2001.","DOI":"10.1046\/j.1468-2982.2001.00173.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Loder E. Naratriptan in the prophylaxis of cluster headache. Headache 42: 56-57, 2002.","DOI":"10.1046\/j.1526-4610.2002.02014.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Mulder LJ, Spierings EL. Naratriptan in the preventive treatment of cluster headache. Cephalalgia 22: 815-817, 2002.","DOI":"10.1046\/j.1468-2982.2002.00424.x"},{"key":"10","unstructured":"10. Kempsford R. Clinical pharmacology and pharmacokinetics of naratriptan. Cephalalgia 17: 473, 1997."},{"key":"11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1468-2982.2003.00824.x","volume":"24","author":"Headache Classification Subcommittee of the International Headache Society null","year":"2004","unstructured":"11. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 24 (Suppl 1): 9-160, 2004.","journal-title":"Cephalalgia","ISSN":"https:\/\/id.crossref.org\/issn\/0333-1024","issn-type":"print"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Headache Classification Committee of the International Headache Society (HIS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33: 629-808, 2013.","DOI":"10.1177\/0333102413485658"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Monstad I, Krabbe A, Micieli G, et al. Preemptive oral treatment with sumatriptan during a cluster period. Headache 35: 607-613, 1995.","DOI":"10.1111\/j.1526-4610.1995.hed3510607.x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/19\/56_8865-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T04:51:25Z","timestamp":1570078285000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/19\/56_8865-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":13,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8865-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}